HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Net Debt

The Net Debt of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 3, 2026 is 289.92 B VND. In the previous year, Net Debt was 121.91 B VND — a change of 137.81% (higher).

Net Debt

289.92 BVND

YoY

137.81%

Last updated:

Net Debt of HaTay Pharmaceutical JSC is 2024 289.92 B VND. Net Debt of HaTay Pharmaceutical JSC was 2023 121.91 B VND. It decreases by 137.81% higher compared to the previous year.

The HaTay Pharmaceutical JSC Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2017
153.04 B VND
Jan 1, 2018
149.49 B VND
Jan 1, 2019
107.41 B VND
Jan 1, 2020
143.69 B VND
Jan 1, 2021
-120.24 B VND
Jan 1, 2022
190.71 B VND
Jan 1, 2023
121.91 B VND
Jan 1, 2024
289.92 B VND
The HaTay Pharmaceutical JSC Net Debt history
YEARNet DebtYoY
289.92 BVND+137.81%
121.91 BVND-36.08%
190.71 BVND-258.61%
-120.24 BVND-183.68%
143.69 BVND+33.77%
107.41 BVND-28.15%
149.49 BVND-2.32%
153.04 BVND+25.42%
122.03 BVND-10.53%
136.38 BVND+49.03%
91.51 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Net Debt of HaTay Pharmaceutical JSC is 289.92 B VND in 2024.

Net Debt of HaTay Pharmaceutical JSC changed from 121.91 B VND to 289.92 B VND, representing a 137.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's HaTay Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — HaTay Pharmaceutical JSC

All Key Metrics — HaTay Pharmaceutical JSC